A股異動 | 雷柏科技(002577.SZ)逼近跌停 料年度業績同比盈轉虧
格隆匯1月20日丨雷柏科技(002577.SZ)今日大幅低開下跌,股價逼近跌停。現跌9.71%,報11.99元,暫成交9161萬,最新總市值33.93億元。

雷柏科技(002577.SZ)2019年度業績預告,公司預計2019年1-12月實現歸屬於上市公司股東的淨利潤為虧損1.05億元-1.45億元,而上年同期為盈利806.82萬元。報告期內,虧損主要與新公司向“輕資產”經營模式轉型過程中關閉生產線,採用外協生產等有關。
雷柏科技如今已成為全球份額位居前列的專業無線外設供應商。其以無線鼠標、無線鍵盤、無線音頻等無線外設產品的研發、生產和銷售做為主營業務。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.